Is marstacimab the next step in personalized and effective haemophilia management?
Expert Review of Clinical Pharmacology · 04.03.2026 · 19 (3) · 211-213
DOI: 10.1080/17512433.2026.2636119 ↗Kurz gefasst
Editorial in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 09.03.2026. Verfasst von Johnny Mahlangu. Beteiligte Einrichtung: Department of Molecular Medicine and Haematology, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Medicine and Haematology, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
ORCID-Profile: Johnny Mahlangu
Zitieren
APA
Mahlangu, J. (2026). Is marstacimab the next step in personalized and effective haemophilia management?. Expert Review of Clinical Pharmacology, 19(3), 211-213. https://doi.org/10.1080/17512433.2026.2636119
Vancouver
Mahlangu J. Is marstacimab the next step in personalized and effective haemophilia management?. Expert Review of Clinical Pharmacology. 2026;19(3):211-213. doi:10.1080/17512433.2026.2636119
BibTeX
@article{Mahlangu2026,
author = {Mahlangu, Johnny},
title = {Is marstacimab the next step in personalized and effective haemophilia management?},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
volume = {19},
number = {3},
pages = {211--213},
doi = {10.1080/17512433.2026.2636119}
}
EUVIMED